Clinical Study Phase 1 study of mTORC 1 / 2 inhibitor sapanisertib ( TAK-228 ) in advanced solid tumours , with an expansion phase in renal , endometrial or bladder cancer

semanticscholar

Cited 0|Views0
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined